Wed, Oct 22, 2014, 6:51 AM EDT - U.S. Markets open in 2 hrs 39 mins

Recent

% | $
Quotes you view appear here for quick access.

XOMA Corporation Message Board

  • hurtstupid hurtstupid Jan 2, 2011 8:18 PM Flag

    Vote for Engle

    For Worst biotech CEO of the year!

    Xoma is one of the country's oldest biotech companies yet has little to show for it except a mountain of losses and years of dismal shareholder returns. Xoma's chosen field of expertise -- the manufacture of humanized monoclonal antibodies -- has helped other companies like Genentech develop successful products. Yet Xoma, working alone, has never been able to develop a drug. The company's R&D graveyard is a crowded place.

    Engle doesn't deserve all the blame for Xoma's long history of futility, but he joined the company in 2007, promising change. He exits 2010 delivering little or nothing. Under Engle, Xoma's drug research still shows no sign of life. Promises he made to partner an early-stage diabetes drug candidate went nowhere, and balance sheet and debt issues diverted way too much time and corporate resources.
    Investors long ago gave up on Xoma. As a result, the stock has slid deeper into the tank, and not even a 1-for-15 reverse stock split needed to maintain a Nasdaq listing has helped turn things around. Xoma shares are down 78% this year.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
XOMA
4.27+0.02(+0.47%)Oct 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.